ArticleCancer chemotherapy and pharmacology2021

Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer.

Shuang Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.